Nomura Asset Management CO LTD Vertex Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

$35.5 Billion
Q2 2025

A detailed history of Nomura Asset Management CO LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 158,916 shares of VRTX stock, worth $67.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

158,916

Previous 153,295 3.67%

Holding current value

$67.6 Million

Previous $74.3 Million 4.8%

% of portfolio

0.2%

Previous 0.23%

43 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$421.16 - $509.5 $2.37 Million - $2.86 Million	5,621 Added 3.67%	158,916 $70.7 Million
Q1 2025 May 12, 2025	BUY	$402.49 - $513.76 $1.41 Million - $1.8 Million	3,496 Added 2.33%	153,295 $74.3 Million
Q4 2024 Feb 12, 2025	SELL	$396.64 - $516.74 $2.02 Million - $2.63 Million	-5,095 Reduced 3.29%	149,799 $60.3 Million
Q3 2024 Nov 15, 2024	BUY	$460.0 - $505.78 $3.14 Million - $3.45 Million	6,831 Added 4.61%	154,894 $72 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $6.56 Million - $8.11 Million	16,701 Added 12.71%	148,063 $69.4 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $7.89 Million - $8.63 Million	-19,353 Reduced 12.84%	131,362 $54.9 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $6.46 Million - $7.73 Million	-18,822 Reduced 11.1%	150,715 $61.3 Million
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $1.3 Million - $1.4 Million	3,852 Added 2.32%	169,537 $59 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $5.98 Million - $6.69 Million	-19,008 Reduced 10.29%	165,685 $58.3 Million
Q1 2023 Jan 10, 2025	SELL	$283.23 - $323.1 $31.7 Million - $36.1 Million	-111,826 Reduced 37.71%	184,693 $58.2 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $31.7 Million - $36.1 Million	-111,826 Reduced 37.71%	184,693 $58.2 Million
Q4 2022 Jan 10, 2025	SELL	$285.76 - $321.48 $6.48 Million - $7.28 Million	-22,660 Reduced 7.1%	296,519 $85.6 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $6.48 Million - $7.28 Million	-22,660 Reduced 7.1%	296,519 $85.6 Million
Q3 2022 Jan 10, 2025	BUY	$273.83 - $305.53 $1.71 Million - $1.9 Million	6,227 Added 1.99%	319,179 $92.4 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $1.71 Million - $1.9 Million	6,227 Added 1.99%	319,179 $92.4 Million
Q2 2022 Jan 10, 2025	SELL	$234.96 - $292.55 $482,137 - $600,312	-2,052 Reduced 0.65%	312,952 $88.2 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $482,137 - $600,312	-2,052 Reduced 0.65%	312,952 $88.2 Million
Q1 2022 Jan 10, 2025	BUY	$221.42 - $260.97 $35.5 Million - $41.8 Million	160,110 Added 103.37%	315,004 $82.2 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $4.02 Million - $4.74 Million	18,150 Added 6.11%	315,004 $82.2 Million
Q4 2021 Jan 10, 2025	BUY	$177.01 - $223.45 $9.95 Million - $12.6 Million	56,197 Added 23.35%	296,854 $65.2 Million
Q4 2021 Feb 01, 2022	BUY	$177.01 - $223.45 $9.95 Million - $12.6 Million	56,197 Added 23.35%	296,854 $65.2 Million
Q3 2021 Jan 10, 2025	BUY	$181.39 - $202.99 $2.3 Million - $2.57 Million	12,681 Added 5.56%	240,657 $43.7 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $2.3 Million - $2.57 Million	12,681 Added 5.56%	240,657 $43.7 Million
Q2 2021 Jan 10, 2025	SELL	$187.49 - $221.1 $2.1 Million - $2.47 Million	-11,180 Reduced 4.67%	227,976 $46 Million
Q2 2021 Aug 06, 2021	SELL	$187.49 - $221.1 $2.1 Million - $2.47 Million	-11,180 Reduced 4.67%	227,976 $46 Million
Q1 2021 Jan 10, 2025	BUY	$207.02 - $241.31 $17.4 Million - $20.3 Million	84,262 Added 54.4%	239,156 $51.4 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $2.44 Million - $2.85 Million	-11,802 Reduced 4.7%	239,156 $51.4 Million
Q4 2020 Jan 10, 2025	BUY	$207.01 - $276.09 $19.9 Million - $26.5 Million	96,064 Added 62.02%	250,958 $59.3 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $2.26 Million - $3.01 Million	10,907 Added 4.54%	250,958 $59.3 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $14.6 Million - $17.3 Million	57,031 Added 31.16%	240,051 $65.3 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $2.73 Million - $3.58 Million	12,100 Added 7.08%	183,020 $53.1 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $22.6 Million - $28 Million	113,007 Added 195.13%	170,920 $40.7 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $592,820 - $796,223	-3,556 Reduced 5.79%	57,913 $12.7 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $587,789 - $661,550	3,536 Added 6.1%	61,469 $10.4 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $57,942 - $67,010	-352 Reduced 0.6%	57,933 $10.6 Million
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $222,345 - $264,402	-1,358 Reduced 2.28%	58,285 $10.7 Million
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $537,609 - $680,231	3,539 Added 6.31%	59,643 $9.88 Million
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $120,094 - $138,001	716 Added 1.29%	56,104 $10.8 Million
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $208,088 - $242,702	-1,428 Reduced 2.51%	55,388 $9.41 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $180,858 - $211,316	1,193 Added 2.14%	56,816 $9.26 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $3.27 Million - $3.71 Million	23,823 Added 74.92%	55,623 $8.34 Million
Q3 2017 Nov 13, 2017	SELL	$148.13 - $162.24 $3.17 Million - $3.47 Million	-21,390 Reduced 40.21%	31,800 $4.84 Million
Q2 2017 Aug 14, 2017	BUY	N/A	53,190	53,190 $6.86 Million

Others Institutions Holding VRTX

# of Institutions

1,784

Shares Held

236M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $109B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Vertex Pharmaceuticals Inc Transaction History